Literature DB >> 15832554

Is a vaccine needed against Candida albicans?

A Brian Mochon1, Jim E Cutler.   

Abstract

The development of a useful Candida vaccine is a distinct possibility despite the fact that individuals with a lifetime of commensal sensitization do not develop sterile immunity to the organism. An effective Candida vaccine would be invaluable in preventing hematogenously disseminated candidiasis, as well as mucocutaneous disease. This review is a discussion of our current understanding of the interplay between commensal and pathogenic forms of Candida albicans and approaches toward active and passive immunoprevention against candidiasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15832554     DOI: 10.1080/13693780500035979

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  16 in total

1.  Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis.

Authors:  Hong Xin; Jim E Cutler
Journal:  Clin Vaccine Immunol       Date:  2011-08-10

2.  Design of a mimotope-peptide based double epitope vaccine against disseminated candidiasis.

Authors:  Hong Xin; Pati Glee; Abby Adams; Farhan Mohiuddin; Karen Eberle
Journal:  Vaccine       Date:  2019-03-28       Impact factor: 3.641

3.  Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis.

Authors:  Stephen P Saville; Anna L Lazzell; Ashok K Chaturvedi; Carlos Monteagudo; Jose L Lopez-Ribot
Journal:  Clin Vaccine Immunol       Date:  2009-01-14

4.  NMR comparison of hyphal and yeast Candida albicans serotype B mannans.

Authors:  Peter Bystrický; Eva Machová; Slavomír Bystrický
Journal:  Eur Biophys J       Date:  2018-04-13       Impact factor: 1.733

Review 5.  Emerging drugs and vaccines for candidemia.

Authors:  Brad Moriyama; Lori A Gordon; Matthew McCarthy; Stacey A Henning; Thomas J Walsh; Scott R Penzak
Journal:  Mycoses       Date:  2014-10-08       Impact factor: 4.377

Review 6.  Adaptive immunity to fungi.

Authors:  Marcel Wüthrich; George S Deepe; Bruce Klein
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

7.  A structurally diversified linker enhances the immune response to a small carbohydrate hapten.

Authors:  Tomasz Lipinski; Thanh Luu; Pavel I Kitov; Adam Szpacenko; David R Bundle
Journal:  Glycoconj J       Date:  2011-05-05       Impact factor: 2.916

Review 8.  Advances in combating fungal diseases: vaccines on the threshold.

Authors:  Jim E Cutler; George S Deepe; Bruce S Klein
Journal:  Nat Rev Microbiol       Date:  2006-12-11       Impact factor: 60.633

9.  Adjuvanticity of a recombinant calreticulin fragment in assisting anti-β-glucan IgG responses in T cell-deficient mice.

Authors:  Wei-Ji Li; Kai Long; Hong-Liang Dong; Xiao-Ming Gao
Journal:  Clin Vaccine Immunol       Date:  2013-02-13

10.  Beta-1,2 oligomannose adhesin epitopes are widely distributed over the different families of Candida albicans cell wall mannoproteins and are associated through both N- and O-glycosylation processes.

Authors:  Chantal Fradin; Marie Christine Slomianny; Céline Mille; Annick Masset; Raymond Robert; Boualem Sendid; Joachim F Ernst; Jean Claude Michalski; Daniel Poulain
Journal:  Infect Immun       Date:  2008-07-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.